Industry Overview

Asia-Pacific CBD gummies market was valued at $971.6 million in 2024 and is projected to reach $11,558.2 million by 2035, growing at a CAGR of 25.3% during the forecast period (2025–2035). The market growth is driven by increasing consumer awareness of CBD's potential benefits for anxiety, sleep, and pain, along with a rising demand for convenient wellness products. Its key factors influencing this growth include favorable regulatory changes in some countries like Australia, the proliferation of online retail, and innovations in product formulation, such as organic and vegan options. However, the market faces restraints from regulatory ambiguity, such as Japan, which is enacting stringent THC limits, and a preference for offline sales channels by some consumers.

Market Dynamics

Rising Health Awareness and Wellness Trends

Increasing consumer awareness regarding health, fitness, and mental well-being is a primary driver for the Asia-Pacific CBD gummies market. Consumers are progressively seeking natural alternatives for stress relief, sleep enhancement, and pain management. CBD gummies are considered a convenient and effective method to consume cannabinoids, fueling demand across countries like China, India, and Japan

Expansion of E-commerce and Digital Retail Channels

The growth of online retail platforms has significantly boosted the accessibility of CBD gummies in the Asia-Pacific region. E-commerce channels allow manufacturers to reach a broader customer base, including remote areas, while offering subscription models, personalized products, and discounts. The online segment is projected to grow faster than offline retail due to the convenience of home delivery and increased awareness through digital marketing campaigns.

Regulatory Developments and Market Liberalization

Progressive regulatory frameworks in key Asia-Pacific countries have enabled the legal production and sale of CBD-based products. For instance, China has introduced policies supporting hemp-derived CBD products, creating a favorable environment for new entrants and expansions by global players. Regulatory clarity reduces market uncertainty, encouraging more companies to invest in research, development, and marketing activities.

Market Segmentation

• Based on the product type, the market is segmented into full-spectrum, broad-spectrum, CBD isolate, and conventional vs. sugar-free.
• Based on the concentration levels, the market is segmented into low-concentration and high-concentration.
• Based on the distribution channel, the market is segmented into online and offline.

Full-Spectrum Largest Segment in the Asia-Pacific CBD Gummies Market

 The full-spectrum CBD gummies segment is expected to lead the Asia-Pacific market, holding the largest share among all product types. Full-spectrum gummies contain multiple cannabinoids, terpenes, and flavonoids, that enhances overall efficacy compared to broad-spectrum or isolate variants. Consumers prefer full-spectrum products for their holistic health benefits, including anxiety reduction, pain relief, and sleep improvement. Its dominance is also reinforced by strong marketing campaigns by leading manufacturers and widespread availability through both online and offline channels.

High Concentration: Key Segment in Market Growth

By concentration level, the high-concentration CBD gummies segment is projected to witness the fastest growth in the Asia-Pacific region. High-concentration products offer potent effects for users seeking targeted therapeutic outcomes, such as chronic pain management and anxiety relief. The rising consumer inclination toward more effective and premium CBD formulations, coupled with a willingness to pay higher prices, supports this trend. Additionally, the online distribution channel serves as a key enabler for growth in this segment, as consumers increasingly prefer ordering high-concentration gummies through digital platforms for convenience, safety, and discreet delivery. Offline channels continue to complement growth, particularly in urban centers, where consumers seek professional advice before purchasing high-potency products.

Regional Outlook

The Asia-Pacific CBD Gummies market is further divided by countries, including India, China, Japan, and the Rest of the Asia-Pacific.

China Dominates the Market with a Major Share

China holds a dominant position in the Asia-Pacific CBD gummies market, capturing a major share due to its rapidly evolving cannabis policy landscape, expanding consumer base, and growing wellness industry. The country’s strong manufacturing capabilities, cost-effective production, and advancements in extraction technologies have made it a hub for CBD-infused products, including gummies. Although China currently restricts domestic CBD consumption, its role as a major exporter of hemp-derived products, particularly CBD isolates and oils used in gummies, has strengthened its market leadership. The increasing demand for plant-based health supplements and functional edibles among the Chinese population has also driven investment and innovation in CBD product development.

Furthermore, China’s large-scale hemp cultivation—mainly in provinces such as Yunnan, Heilongjiang, and Jilin—provides a steady supply of raw materials, giving the country a competitive edge in the regional CBD supply chain. Strategic partnerships between Chinese manufacturers and international wellness brands have facilitated the introduction of premium CBD gummy formulations tailored for export and potential domestic market entry once regulations ease. As regulatory clarity improves and consumer awareness of CBD’s therapeutic benefits rises, China is expected to further consolidate its leadership in the Asia-Pacific CBD gummies sector over the forecast period.

Market Players Outlook

The major companies operating in the Asia-Pacific CBD gummies market include Amway, Church & Dwight, GSK plc, H&H Group, and Procaps Group and others. The companies are pursuing partnerships, collaborations, mergers, and acquisitions to drive innovation, expand product portfolios, enhance sustainability, and strengthen market presence. These strategies enable players to respond to growing demand for energy-efficient, high-performance insulation solutions across residential, commercial, and industrial applications while maintaining a competitive edge.

Recent Developments

• In March 2025, Amway launched a new line of full-spectrum CBD gummies in China with enhanced bioavailability and natural flavoring.
• In May 2025, GSK plc partnered with local distributors in India to expand the availability of CBD gummies through pharmacies and wellness stores.
• In July 2025, H&H Group introduced sugar-free and high-concentration CBD gummies in Japan, targeting health-conscious consumers and premium markets.
• In August 2025, Procaps Group completed the acquisition of a local CBD manufacturer in China to strengthen its product portfolio and distribution capabilities.

The Report Covers

• Market value data analysis of 2024 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the Asia-Pacific CBD gummies market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.